Atlas FDA

DEXCOM SEVEN & SEVEN PLUS SYSTEM

FDA premarket approval P050012/S044 · decided 2012-03-08

Approval details

PMA number
P050012
Supplement
S044
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
DEXCOM SEVEN & SEVEN PLUS SYSTEM
Generic name
Sensor, glucose, invasive
Applicant
Dexcom, Inc.
Date received
2012-01-03
Decision date
2012-03-08
Days to decision
65 days
Decision code
APPR
Product code
MDS
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
APPROVAL FOR A FIRMWARE MODIFICATION TO THE RECEIVED COMPONENT OF THE DEVICE IN ORDER TO INCREASE THE TONE AND DURATION OF USER ALERTS AND ALARMS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stelo Glucose Biosensor System (K260935)Dexcom, Inc.2026-06-12
Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System (K261402)Dexcom, Inc.2026-06-08
Stelo Glucose Biosensor System (K261359)Dexcom, Inc.2026-05-21
Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253737)Dexcom, Inc.2026-02-03
Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253710)Dexcom, Inc.2025-12-17
Dexcom Smart Basal (K252818)Dexcom, Inc.2025-11-18
Dexcom G7 15 Day Continuous Glucose Monitoring System (K243214)Dexcom, Inc.2025-04-09
Dexcom G7 Continuous Glucose Monitoring System (K240902)Dexcom, Inc.2024-04-23